447 related articles for article (PubMed ID: 20458826)
1. Cardiopulmonary involvement in Fabry's disease.
Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
[TBL] [Abstract][Full Text] [Related]
2. New insights in cardiac structural changes in patients with Fabry's disease.
Linhart A; Palecek T; Bultas J; Ferguson JJ; Hrudová J; Karetová D; Zeman J; Ledvinová J; Poupetová H; Elleder M; Aschermann M
Am Heart J; 2000 Jun; 139(6):1101-8. PubMed ID: 10827394
[TBL] [Abstract][Full Text] [Related]
3. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Fabry's disease: an unusual cause of left ventricular hypertrophy.
Nunes JP; Costa O; Faria Mdo S; Almeida PB; Lacerda L
Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):630-3. PubMed ID: 17957210
[TBL] [Abstract][Full Text] [Related]
6. Is left ventricular hypertrabeculation/ noncompaction a cardiac manifestation of Fabry's disease?
Stöllberger C; Finsterer J; Voigtländer T; Slany J
Z Kardiol; 2003 Nov; 92(11):966-9. PubMed ID: 14634768
[TBL] [Abstract][Full Text] [Related]
7. An unusual cause of dyspnea.
Jamali AH; Ahmed RM; Stein H
Cardiol Rev; 2004; 12(1):10-4. PubMed ID: 14667257
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial disease in inherited disease].
Nakao S
Nihon Rinsho; 2000 Jan; 58(1):200-3. PubMed ID: 10885314
[TBL] [Abstract][Full Text] [Related]
9. Many Faces of Fabry's Cardiomyopathy.
Jain R; Kalvin L; Johnson B; Muthukumar L; Khandheria BK; Tajik AJ
JACC Cardiovasc Imaging; 2018 Apr; 11(4):644-647. PubMed ID: 29361493
[No Abstract] [Full Text] [Related]
10. [Cardiac manifestations in Fabry disease].
Lappegård KT; Aass H
Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2395-6. PubMed ID: 11475223
[TBL] [Abstract][Full Text] [Related]
11. Cardiac performance during exercise in patients with Fabry's disease.
Spinelli L; Nicolai E; Acampa W; Imbriaco M; Pisani A; Rao MA; Scopacasa F; Cianciaruso B; De Luca N; Cuocolo A
Eur J Clin Invest; 2008 Dec; 38(12):910-7. PubMed ID: 19021715
[TBL] [Abstract][Full Text] [Related]
12. Fabry's disease presenting as ventricular tachycardia and left ventricular 'hypertrophy'.
Joshi SB; Ahmar W; Lee G; Aggarwal A
Eur J Echocardiogr; 2008 Sep; 9(5):697-9. PubMed ID: 18490300
[TBL] [Abstract][Full Text] [Related]
13. [Cardiac manifestations of Fabry's disease].
Han ZH; Jiang TY; Ren XJ; Wu XS; Zhang WD; Chen F
Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):462-4. PubMed ID: 19954039
[TBL] [Abstract][Full Text] [Related]
14. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K
Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899
[TBL] [Abstract][Full Text] [Related]
15. [Ocular findings in Fabry's disease].
Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
[TBL] [Abstract][Full Text] [Related]
16. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
Tanaka H; Adachi K; Yamashita Y; Toshima H; Koga Y
J Cardiol; 1988 Sep; 18(3):705-18. PubMed ID: 2977798
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
Spinelli L; Pisani A; Sabbatini M; Petretta M; Andreucci MV; Procaccini D; Lo Surdo N; Federico S; Cianciaruso B
Clin Genet; 2004 Aug; 66(2):158-65. PubMed ID: 15253767
[TBL] [Abstract][Full Text] [Related]
18. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease.
Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S
Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651
[TBL] [Abstract][Full Text] [Related]
19. [Myocardial involvement in female Fabry's disease: evaluation by thallium-201 myocardial scintigraphy].
Tsuda T; Yokoyama A; Masani F; Kodera K; Yamamoto T; Watanabe K; Izumi T; Shibata A; Kimura M
J Cardiol; 1988 Mar; 18(1):135-44. PubMed ID: 2975703
[TBL] [Abstract][Full Text] [Related]
20. Neurological manifestations in Fabry's disease.
Møller AT; Jensen TS
Nat Clin Pract Neurol; 2007 Feb; 3(2):95-106. PubMed ID: 17279083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]